Size-dependent tissue kinetics of PEG-coated gold nanoparticles

Toxicology and Applied Pharmacology

Volumn 245, Issue 1, 2010, Pages 116-123

  Cho, Wan Seob ^a,b   Cho, Minjung ^b   Jeong, Jinyoung ^c   Choi, Mina ^b   Han, Beom Seok ^b   Shin, Hyung Seon ^d   Hong, Jin ^b   Chung, Bong Hyun ^c   Jeong, Jayoung ^b   Cho, Myung Haing ^e  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b Korea Food and Drug Administration   (South Korea)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^d Korea Basic Science Institute (KBSI)   (South Korea)

^e Seoul National University   (South Korea)

Author keywords

Gold nanoparticles; Metabolism; Mouse; Size dependent kinetics

Indexed keywords

CYTOCHROME P450 1A1; CYTOCHROME P450 2B; GOLD NANOPARTICLE; MACROGOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOPLASM VESICLE; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG LIVER LEVEL; DRUG METABOLISM; DRUG TISSUE LEVEL; ENZYME ACTIVATION; KUPFFER CELL; LYSOSOME; MACROPHAGE; MALE; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PARTICLE SIZE; RETICULOENDOTHELIAL SYSTEM; SPLEEN; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP2B1; GOLD; KUPFFER CELLS; LIVER; LYMPH NODES; LYSOSOMES; MALE; METABOLIC DETOXICATION, PHASE I; METAL NANOPARTICLES; MICE; MICE, INBRED BALB C; PARTICLE SIZE; POLYETHYLENE GLYCOLS; SPLEEN;

MUS;

EID: 77952544466     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2010.02.013     Document Type: Article

References (46)

1. Abbott B.D., Buckalew A.R., DeVito M.J., Ross D., Bryant P.L., Schmid J.E. EGF and TGF-alpha expression influence the developmental toxicity of TCDD: dose response and AhR phenotype in EGF, TGF-alpha, and EGF+TGF-alpha knockout mice. Toxicol. Sci. 2003, 71:84-95.
2. Baulig A., Garlatti M., Bonvallot V., Marchand A., Barouki R., Marano F., Baeza-Squiban A. Involvement of reactive oxygen species in the metabolic pathways triggered by diesel exhaust particles in human airway epithelial cells. Am. J. Physiol. Lung. Cell Mol. Physiol. 2003, 285:L671-679.
3. Cho M., Cho W.S., Choi M., Kim S.J., Han B.S., Kim S.H., Kim H.O., Sheen Y.Y., Jeong J. The impact of size on tissue distribution and elimination by single intravenous injection of silica nanoparticles. Toxicol. Lett. 2009, 189:177-183.
4. Cho W.S., Cho M., Jeong J., Choi M., Cho H.Y., Han B.S., Kim S.H., Kim H.O., Lim Y.T., Chung B.H. Acute toxicity and pharmacokinetics of 13nm-sized PEG-coated gold nanoparticles. Toxicol. Appl. Pharmacol. 2009, 236:16-24.
5. Cho W.S., Cho M., Kim S.R., Choi M., Lee J.Y., Han B.S., Park S.N., Yu M.K., Jon S., Jeong J. Pulmonary toxicity and kinetic study of Cy5.5-conjugated superparamagnetic iron oxide nanoparticles by optical imaging. Toxicol. Appl. Pharmacol. 2009, 239:106-115.
6. Cho W.S., Kim S., Han B.S., Son W.C., Jeong J. Comparison of gene expression profiles in mice liver following intravenous injection of 4 and 100nm-sized PEG-coated gold nanoparticles. Toxicol. Lett. 2009, 191:96-102.
7. Choi H.S., Liu W., Misra P., Tanaka E., Zimmer J.P., Itty Ipe B., Bawendi M.G., Frangioni J.V. Renal clearance of quantum dots. Nat. Biotechnol. 2007, 25:1165-1170.
8. Daniel M.C., Astruc D. Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem. Rev. 2004, 104:293-346.
9. De Jong W.H., Hagens W.I., Krystek P., Burger M.C., Sips A.J., Geertsma R.E. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials 2008, 29:1912-1919.
10. De Vito M.J., Maier W.E., Diliberto J.J., Birnbaum L.S. Comparative ability of various PCBs, PCDFs, and TCDD to induce cytochrome P450 1A1 and 1A2 activity following 4weeks of treatment. Fundam. Appl. Toxicol. 1993, 20:125-130.
11. Duffin R., Tran L., Brown D., Stone V., Donaldson K. Proinflammogenic effects of low-toxicity and metal nanoparticles in vivo and in vitro: highlighting the role of particle surface area and surface reactivity. Inhal. Toxicol. 2007, 19:849-856.
12. El-Sayed I.H., Huang X., El-Sayed M.A. Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: applications in oral cancer. Nano Lett. 2005, 5:829-834.
13. Frans G. Controlled nucleation for the regulation of the particle size in monodisperse gold suspensions. Nat. (London) Phys. Sci. 1973, 241:20-22.
14. Han G., Ghosh P., Rotello V.M. Functionalized gold nanoparticles for drug delivery. Nanomed. 2007, 2:113-123.
15. Hawkins B.T., Davis T.P. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol. Rev. 2005, 57:173-185.
16. Herrwerth S., Eck W., Reinhardt S., Grunze M. Factors that determine the protein resistance of oligoether self-assembled monolayers - internal hydrophilicity, terminal hydrophilicity, and lateral packing density. J. Am. Chem. Soc. 2003, 125:9359-9366.
17. Huang W., Qian W., Jain P.K., El-Sayed M.A. The effect of plasmon field on the coherent lattice phonon oscillation in electron-beam fabricated gold nanoparticle pairs. Nano Lett. 2007, 7:3227-3234.
18. Huang X.L., Zhang B., Ren L., Ye S.F., Sun L.P., Zhang Q.Q., Tan M.C., Chow G.M. In vivo toxic studies and biodistribution of near infrared sensitive Au-Au(2)S nanoparticles as potential drug delivery carriers. J. Mater. Sci. Mater. Med. 2008, 19:2581-2588.
19. Ichinose T., Yajima Y., Nagashima M., Takenoshita S., Nagamachi Y., Sagai M. Lung carcinogenesis and formation of 8-hydroxy-deoxyguanosine in mice by diesel exhaust particles. Carcinogenesis 1997, 18:185-192.
20. Iwai K., Higuchi K., Udagawa T., Ohtomo K., Kawabata Y. Lung tumor induced by long-term inhalation or intratracheal instillation of diesel exhaust particles. Exp. Toxicol. Pathol. 1997, 49:393-401.
21. Jana N.R., Gearheart L., Murphy C.J. Wet chemical synthesis of high aspect ratio cylindrical gold nanorods. J. Phys. Chem. B 2001, 105:4065-4067.
22. Kattumuri V., Katti K., Bhaskaran S., Boote E.J., Casteel S.W., Fent G.M., Robertson D.J., Chandrasekhar M., Kannan R., Katti K.V. Gum arabic as a phytochemical construct for the stabilization of gold nanoparticles: in vivo pharmacokinetics and X-ray-contrast-imaging studies. Small 2007, 3:333-341.
23. Kim J.S., Yoon T.J., Yu K.N., Kim B.G., Park S.J., Kim H.W., Lee K.H., Park S.B., Lee J.K., Cho M.H. Toxicity and tissue distribution of magnetic nanoparticles in mice. Toxicol. Sci. 2006, 89:338-347.
24. Kim T., Lee K., Gong M.S., Joo S.W. Control of gold nanoparticle aggregates by manipulation of interparticle interaction. Langmuir 2005, 21:9524-9528.
25. Kwon J.T., Hwang S.K., Jin H., Kim D.S., Minai-Tehrani A., Yoon H.J., Choi M., Yoon T.J., Han D.Y., Kang Y.W., Yoon B.I., Lee J.K., Cho M.H. Body distribution of inhaled fluorescent magnetic nanoparticles in the mice. J. Occup. Health 2008, 50:1-6.
26. Lopez-Viota J., Mandal S., Delgado A.V., Toca-Herrera J.L., Moller M., Zanuttin F., Balestrino M., Krol S. Electrophoretic characterization of gold nanoparticles functionalized with human serum albumin (HSA) and creatine. J. Colloid Interface Sci. 2009, 332:215-223.
27. Lu S., Duffin R., Poland C., Daly P., Murphy F., Drost E., Macnee W., Stone V., Donaldson K. Efficacy of simple short-term in vitro assays for predicting the potential of metal oxide nanoparticles to cause pulmonary inflammation. Environ. Health Perspect. 2009, 117:241-247.
28. Mroz R.M., Schins R.P., Li H., Jimenez L.A., Drost E.M., Holownia A., MacNee W., Donaldson K. Nanoparticle-driven DNA damage mimics irradiation-related carcinogenesis pathways. Eur. Respir. J. 2008, 31:241-251.
29. Murphy C.J., Gole A.M., Stone J.W., Sisco P.N., Alkilany A.M., Goldsmith E.C., Baxter S.C. Gold nanoparticles in biology: beyond toxicity to cellular imaging. Acc. Chem. Res. 2008, 41:1721-1730.
30. O'Neal D.P., Hirsch L.R., Halas N.J., Payne J.D., West J.L. Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett. 2004, 209:171-176.
31. Philpot R.M., Smith B.R. Role of cytochrome P-450 and related enzymes in the pulmonary metabolism of xenobiotics. Environ. Health Perspect. 1984, 55:359-367.
32. Qian X., Peng X.H., Ansari D.O., Yin-Goen Q., Chen G.Z., Shin D.M., Yang L., Young A.N., Wang M.D., Nie S. In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags. Nat. Biotechnol. 2008, 26:83-90.
33. Rehor A., Schmoekel H., Tirelli N., Hubbell J.A. Functionalization of polysulfide nanoparticles and their performance as circulating carriers. Biomaterials 2008, 29:1958-1966.
34. Rengasamy A., Barger M.W., Kane E., Ma J.K., Castranova V., Ma J.Y. Diesel exhaust particle-induced alterations of pulmonary phase I and phase II enzymes of rats. J. Toxicol. Environ. Health A 2003, 66:153-167.
35. Renne R.A., Dungworth D.L., Keenan C.M., Morgan K.T., Hahn F.F., Schwartz L.W. Non-proliferative lesions of the respiratory tract in rats. Guides for Toxicologic Pathology 2003, STP/ARP/AFIP, Washington, DC.
36. Sager T.M., Castranova V. Surface area of particle administered versus mass in determining the pulmonary toxicity of ultrafine and fine carbon black: comparison to ultrafine titanium dioxide. Part Fibre Toxicol. 2009, 6:15.
37. Salem A.K., Searson P.C., Leong K.W. Multifunctional nanorods for gene delivery. Nat. Mater. 2003, 2:668-671.
38. Schlezinger J.J., White R.D., Stegeman J.J. Oxidative inactivation of cytochrome P-450 1A (CYP1A) stimulated by 3, 3′, 4, 4′-tetrachlorobiphenyl: production of reactive oxygen by vertebrate CYP1As. Mol. Pharmacol. 1999, 56:588-597.
39. Semmler-Behnke M., Kreyling W.G., Lipka J., Fertsch S., Wenk A., Takenaka S., Schmid G., Brandau W. Biodistribution of 1.4- and 18-nm gold particles in rats. Small 2008, 4:2108-2111.
40. Sonavane G., Tomoda K., Makino K. Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. Colloids Surf. B Biointerfaces 2008, 66:274-280.
41. Stone V., Donaldson K. Nanotoxicology: signs of stress. Nat. Nanotechnol. 2006, 1:23-24.
42. Terentyuk G.S., Maslyakova G.N., Suleymanova L.V., Khlebtsov B.N., Kogan B.Y., Akchurin G.G., Shantrocha A.V., Maksimova I.L., Khlebtsov N.G., Tuchin V.V. Circulation and distribution of gold nanoparticles and induced alterations of tissue morphology at intravenous particle delivery. J. Biophotonics 2009, 2:292-302.
43. Upadhyay G., Singh A.K., Kumar A., Prakash O., Singh M.P. Resveratrol modulates pyrogallol-induced changes in hepatic toxicity markers, xenobiotic metabolizing enzymes and oxidative stress. Eur. J. Pharmacol. 2008, 596:146-152.
44. Whitlock J.P. Induction of cytochrome P4501A1. Annu. Rev. Pharmacol. Toxicol. 1999, 39:103-125.
45. Zhang G., Yang Z., Lu W., Zhang R., Huang Q., Tian M., Li L., Liang D., Li C. Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice. Biomaterials 2009, 30:1928-1936.
46. Zhao H.W., Barger M.W., Ma J.K., Castranova V., Ma J.Y. Effects of exposure to diesel exhaust particles (DEP) on pulmonary metabolic activation of mutagenic agents. Mutat. Res. 2004, 564:103-113.